Dual-vector prodrug activator gene therapy using retroviral replicating vectors (Q57801682)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30348946%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

title

Dual-vector prodrug activator gene therapy using retroviral replicating vectors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30348946%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30348946%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30348946%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Misato Takagi-Kimura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30348946%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Masatoshi Tagawa

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30348946%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

language of work or name

English

0 references

publication date

22 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30348946%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30348946%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30348946%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

issue

5-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30348946%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

page(s)

128-135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30348946%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

29 April 2020

start time

22 October 2018

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Gene therapy for cancer: what have we done and where are we going?

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Clinical trials with retrovirus mediated gene therapy--what have we learned?

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Gene therapy progress and prospects cancer: oncolytic viruses.

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Oncolytic virotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Tumor-selective gene expression in a hepatic metastasis model after locoregional delivery of a replication-competent retrovirus vector

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Highly efficient tumor transduction and antitumor efficacy in experimental human malignant mesothelioma using replicating gibbon ape leukemia virus

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma model

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma.

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

The receptors for gibbon ape leukemia virus and amphotropic murine leukemia virus are not downregulated in productively infected cells

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Prodrug-activating systems in suicide gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Suicide genes for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Retroviral superinfection resistance

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Episodic Diversifying Selection Shaped the Genomes of Gibbon Ape Leukemia Virus and Related Gammaretroviruses.

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Transspecies Transmission of Gammaretroviruses and the Origin of the Gibbon Ape Leukaemia Virus (GaLV) and the Koala Retrovirus (KoRV)

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Synergistic Anticancer Effects of Ganciclovir/Thymidine Kinase and 5-Fluorocytosine/Cytosine Deaminase Gene Therapies

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Ganciclovir-induced apoptosis in HSV-1 thymidine kinase expressing cells: critical role of DNA breaks, Bcl-2 decline and caspase-9 activation

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system

1 reference

https://api.crossref.org/works/10.1038%2FS41417-018-0051-0

7 January 2021

Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30348946

12 December 2020

inferred from PubMed ID database lookup

Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30348946

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/S41417-018-0051-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30348946%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30348946%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

PubMed publication ID

30348946

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30348946%20AND%20SRC:MED&resulttype=core&format=json